Loading quote...
Spero Therapeutics, Inc. (SPRO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. The most recent ex-dividend date was September 16, 2015, with payment scheduled for October 7, 2015. market capitalization is approximately $141M.